logoThe People's Perspective on Medicine

Losartan and Suicide? Another ARB (Sartan) Concern

Canadian scientists have found a link between losartan and suicide that also implicates similar drugs such as irbesartan or valsartan.
Losartan and Suicide? Another ARB (Sartan) Concern
Elderly woman pensioner measures the blood pressure itself.

Over the last 15 months, millions of blood pressure pills called ARBs have been recalled due to contamination with nitrosamines. Many people with hypertension worried about a possible increased risk of cancer linked to drugs like valsartan. Now there is another concern with this class of medications. A study in JAMA Network Open (Oct. 16, 2019) has found an association between ARBs like losartan and suicide. Is there reason for concern?

What Are ARBs?

ARB stands for angiotensin receptor blocker. These are drugs like candesartan, irbesartan, losartan, olmesartan, telmisartan and valsartan. You probably noticed that they all have “sartan” as part of the suffix of each drug.

They work by interfering with the action of a natural chemical called angiotensin II. If this vasoconstrictor cannot reach its receptors, blood vessels dilate and blood pressure comes down. You can learn more about the way ACE inhibitors and ARBS work at this link.

Another Day Another Losartan Recall | Can We Trust the FDA?

ARBs are among the most prescribed antihypertensive medications in the country. That’s largely because they are perceived to cause fewer side effects than their cousins, the ACE inhibitors (ACEIs) that include drugs like lisinopril, enalapril or ramipril.

Losartan and Suicide: Real or Imaginary?

In the new study, Canadian researchers analyzed data collected between 1995 and 2015. People were 66 years of age or older and were taking either ARBs or ACE inhibitors. They compared 964 older adults who died by suicide with 3,856 matched controls. The investigators found that exposure to ARB-type blood pressure medications was linked to a higher risk of death by suicide compared with exposure to ACE inhibitors.

Why Do This Research?

The investigators explain why they undertook this study:

“…recent data suggest that users of ARBs, but not ACEIs, may have an increased risk of suicide compared with nonusers. The objective of our study was to examine the association between suicide and exposure to ARBs compared with ACEIs.”

The potential mechanism involves the chemical angiotensin II (AII). Most primary care physicians, internists and cardiologists think about this chemical in terms of blood vessel constriction. But it also affects the brain.

The authors of the new study offer this complicated explanation:

“The mechanisms by which ARBs or ACEIs might impart differential risks of suicide are unknown. As noted earlier, higher levels of AII may increase levels of substance P, which may, in turn, promote stress and anxiety… Another possible explanation for a higher risk of suicide among users of ARBs is associated with the upregulation of AII and resulting unopposed stimulation of AII type 2 receptors. These effects have been associated with nuclear factor–κB pathway activation, a process increasingly recognized as being involved in the pathophysiology of mood disorders.”

We know that’s an in-the-weeds hypothesis.

Here is what an accompanying editorial (JAMA Network Open, Oct. 16, 2019) has to say about this:

“There is a body of evidence indicating that angiotensin has a role in modulating brain activity, behavior, and possibly, mood…”

The author of the editorial concludes:

“To summarize, the report by Mamdani et al that ARBs are associated with increases in the risk of suicide in a study using real-world data requires conceptual replication. The strength of the methods, the importance of preventing suicide, and the number of people exposed to ARBs all support the need to encourage additional studies and to translate the combined findings into guidance about prescribing.”

The authors of the original study suggest that since the two classes of medication have similar effectiveness, clinicians may want to favor ACE inhibitors over ARBs when possible.

What has been your experience with ARBs or ACEIs? Please share your thoughts in the comment section below.

If you find this kind of drug information important, please consider supporting our work. Google has made our content virtually invisible to Internet search. You can learn how to keep this independent watchdog website strong by going to this link.

Rate this article
star-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-empty
4.9- 8 ratings
About the Author
Joe Graedon is a pharmacologist who has dedicated his career to making drug information understandable to consumers. His best-selling book, The People’s Pharmacy, was published in 1976 and led to a syndicated newspaper column, syndicated public radio show and web site. In 2006, Long Island University awarded him an honorary doctorate as “one of the country's leading drug experts for the consumer.” .
Blood Pressure Treatment
$4.99

Learn about pros and cons of the various medicines used to lower blood pressure, as well as multiple non-drug approaches to blood pressure control such as diet, supplements and special foods.

Blood Pressure Treatment
Citations
  • Mamdani M et al, "Association between angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and suicide." JAMA Network Open, Oct. 16, 2019. doi:10.1001/jamanetworkopen.2019.13304
Join over 150,000 Subscribers at The People's Pharmacy

We're empowering you to make wise decisions about your own health, by providing you with essential health information about both medical and alternative treatment options.